You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.

View our list of the best stock brokerages

Other companies in Ultragenyx Pharmaceutical’s space includes: Immunome Inc (NASDAQ:IMNM), Sarepta Therapeutics Inc (NASDAQ:SRPT), Syndax Pharmaceuticals Inc (NASDAQ:SNDX), Ascentage Pharma Group International (NASDAQ:AAPG) and Day One Biopharmaceuticals Inc (NASDAQ:DAWN).

Ultragenyx Pharmaceutical has a consensus price target of $75.89.

The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $20.26 last updated March 20, 2026 at 5:38 PM EDT.

There are no upcoming dividends for Ultragenyx Pharmaceutical.

Ultragenyx Pharmaceutical does not have any upcoming earnings scheduled.

There is no upcoming split for Ultragenyx Pharmaceutical.

Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.